PLoS ONE (Jan 2014)

Novel and recurrent MYO7A mutations in Usher syndrome type 1 and type 2.

  • Weining Rong,
  • Xue Chen,
  • Kanxing Zhao,
  • Yani Liu,
  • Xiaoxing Liu,
  • Shaoping Ha,
  • Wenzhou Liu,
  • Xiaoli Kang,
  • Xunlun Sheng,
  • Chen Zhao

DOI
https://doi.org/10.1371/journal.pone.0097808
Journal volume & issue
Vol. 9, no. 5
p. e97808

Abstract

Read online

Usher syndrome (USH) is a group of disorders manifested as retinitis pigmentosa and bilateral sensorineural hearing loss, with or without vestibular dysfunction. Here, we recruited three Chinese families affected with autosomal recessive USH for detailed clinical evaluations and for mutation screening in the genes associated with inherited retinal diseases. Using targeted next-generation sequencing (NGS) approach, three new alleles and one known mutation in MYO7A gene were identified in the three families. In two families with USH type 1, novel homozygous frameshift variant p.Pro194Hisfs*13 and recurrent missense variant p.Thr165Met were demonstrated as the causative mutations respectively. Crystal structural analysis denoted that p.Thr165Met would very likely change the tertiary structure of the protein encoded by MYO7A. In another family affected with USH type 2, novel biallelic mutations in MYO7A, c.[1343+1G>A];[2837T>G] or p.[?];[Met946Arg], were identified with clinical significance. Because MYO7A, to our knowledge, has rarely been correlated with USH type 2, our findings therefore reveal distinguished clinical phenotypes associated with MYO7A. We also conclude that targeted NGS is an effective approach for genetic diagnosis for USH, which can further provide better understanding of genotype-phenotype relationship of the disease.